# NasoNeb Delivery of an Intranasal Steroid

> **NCT01270256** · PHASE4 · COMPLETED · sponsor: **University of Chicago** · enrollment: 41 (actual)

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01270256
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-07
- **Final completion:** 2012-08
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270256, "NasoNeb Delivery of an Intranasal Steroid". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01270256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*